Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor

Prostate cancer is a major cause of death in males. Cyproterone acetate (CPA), the steroidal anti-androgen for part of androgen deprivation therapy, may block the androgen-receptor interaction and then reduce serum testosterone through its weak anti-gonadotropic action. In addition to CPA inducing h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chih-Shou, Gao, Guan-Lun, Ho, Dong-Ru, Lin, Chih-Yi, Chou, Yu-Ting, Chen, Shan-Chun, Huang, Min-Cong, Kao, Wen-Ya, Su, Jyan-Gwo Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943802/
https://www.ncbi.nlm.nih.gov/pubmed/33750846
http://dx.doi.org/10.1038/s41598-021-84769-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943802/
https://www.ncbi.nlm.nih.gov/pubmed/33750846
http://dx.doi.org/10.1038/s41598-021-84769-7

Ejemplares similares